Humanin ameliorates TBI-related cognitive impairment by attenuating mitochondrial dysfunction and inflammation

Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166937. doi: 10.1016/j.bbadis.2023.166937. Epub 2023 Nov 4.

Abstract

Traumatic brain injury (TBI) often results in a reduction of the capacity of cells to sustain energy demands, thus, compromising neuronal function and plasticity. Here we show that the mitochondrial activator humanin (HN) counteracts a TBI-related reduction in mitochondrial bioenergetics, including oxygen consumption rate. HN normalized the disruptive action of TBI on memory function, and restored levels of synaptic proteins (synapsin 1 and p-CREB). HN also counteracted TBI-related elevations of pro-inflammatory cytokines in plasma (TNF-α, INF-y, IL 17, IL 5, MCP 5, GCSF, RANNETS, sTNFRI) as well as in the hippocampus (gp-130 and p-STAT3). Gp-130 is an integral part of cytokine receptor impinging on STAT3 (Tyr-705) signaling. Furthermore, HN reduced astrocyte proliferation in TBI. The overall evidence suggests that HN plays an integral role in normalizing fundamental aspects of TBI pathology which are central to energy balance, brain function, and plasticity.

Keywords: Astrogliosis; Inflammation; Mitochondrial bioenergetics; Synaptic plasticity; Traumatic brain injury.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins
  • Brain Injuries, Traumatic* / complications
  • Brain Injuries, Traumatic* / drug therapy
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / etiology
  • Inflammation / drug therapy
  • Mitochondrial Diseases*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • humanin
  • Apoptosis Regulatory Proteins